Sanara MedTech (SMTI) to Release Quarterly Earnings on Tuesday

Sanara MedTech (NASDAQ:SMTI) will issue its quarterly earnings data after the market closes on Tuesday, November 12th. Individual that wish to register for the company’s earnings conference call can do so using this link.

Sanara MedTech (NASDAQ:SMTI) last released its earnings results on Monday, August 12th. The company reported ($0.41) earnings per share for the quarter. The business had revenue of $20.16 million for the quarter. Sanara MedTech had a negative return on equity of 15.17% and a negative net margin of 9.07%.

Sanara MedTech Trading Up 3.9 %

Shares of SMTI stock opened at $35.24 on Friday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.49 and a current ratio of 1.80. Sanara MedTech has a fifty-two week low of $26.00 and a fifty-two week high of $43.25. The company has a market cap of $308.35 million, a PE ratio of -45.18 and a beta of 1.55. The stock’s fifty day moving average price is $32.38 and its two-hundred day moving average price is $31.20.

Sanara MedTech Company Profile

Sanara MedTech Inc, a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers.